Erasca Correlations

ERAS Stock  USD 1.48  0.04  2.78%   
The current 90-days correlation between Erasca Inc and Keros Therapeutics is 0.21 (i.e., Modest diversification). The correlation of Erasca is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.

Erasca Correlation With Market

Modest diversification

The correlation between Erasca Inc and DJI is 0.29 (i.e., Modest diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Erasca Inc and DJI in the same portfolio, assuming nothing else is changed.
  
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Erasca Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

Moving together with Erasca Stock

  0.79ME 23Andme HoldingPairCorr
  0.78VANI Vivani Medical Earnings Call This WeekPairCorr
  0.93VERA Vera TherapeuticsPairCorr
  0.64CDIOW Cardio DiagnosticsPairCorr
  0.79DSGN Design TherapeuticsPairCorr
  0.93VINC Vincerx Pharma Earnings Call Next WeekPairCorr
  0.95VKTX Viking TherapeuticsPairCorr
  0.74DYAI Dyadic International Earnings Call This WeekPairCorr
  0.81VRDN Viridian TherapeuticsPairCorr
  0.79VRPX Virpax PharmaceuticalsPairCorr
  0.86VTRS ViatrisPairCorr
  0.94VTYX Ventyx BiosciencesPairCorr

Moving against Erasca Stock

  0.86VALN Valneva SE ADRPairCorr
  0.71VIGL Vigil NeurosciencePairCorr
  0.65DMAC DiaMedica TherapeuticsPairCorr
  0.57DVAX Dynavax TechnologiesPairCorr
  0.48EQ EquilliumPairCorr
  0.41VERV Verve TherapeuticsPairCorr
  0.35DTIL Precision BioSciences Earnings Call This WeekPairCorr
  0.94VRNA Verona Pharma PLCPairCorr
  0.7VRTX Vertex PharmaceuticalsPairCorr
  0.61EDSA Edesa BiotechPairCorr
  0.59VTVT vTv TherapeuticsPairCorr
  0.58SRZNW Surrozen WarrantPairCorr
  0.52VSTM VerastemPairCorr

Related Correlations Analysis

Click cells to compare fundamentals   Check Volatility   Backtest Portfolio

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.
High positive correlations   
CCCCIPSC
DSGNIPSC
GLUEKROS
DSGNGLUE
KROSIPSC
GLUEIPSC
  
High negative correlations   
MLYSCCCC
MLYSTHRX
CCCCTHRX
EWTXTHRX
DSGNTHRX
MLYSGRCL

Risk-Adjusted Indicators

There is a big difference between Erasca Stock performing well and Erasca Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Erasca's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
IPSC  2.96 (1.08) 0.00 (0.74) 0.00 
 5.88 
 17.02 
NGM  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
KROS  4.01 (1.73) 0.00 (274.04) 0.00 
 4.41 
 76.68 
GLUE  3.51 (0.31) 0.00 (0.33) 0.00 
 7.34 
 19.92 
GRCL  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
THRX  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
DSGN  4.48 (0.24) 0.00 (0.44) 0.00 
 9.45 
 26.51 
EWTX  2.88  0.06  0.00 (0.05) 0.00 
 5.32 
 26.44 
CCCC  3.52 (0.77) 0.00 (0.41) 0.00 
 7.10 
 20.72 
MLYS  4.27  0.28  0.11 (0.25) 4.47 
 10.04 
 50.53 

Erasca Corporate Management

Michael VarneyScientific DevelopmentProfile
Lisa TesvichBonoraChief OfficerProfile
Nik ChetwynVP OperationsProfile
CPA MSVP FinProfile
Wei MDChief OfficerProfile
JD EsqGeneral SecretaryProfile
Esq JDGeneral SecretaryProfile